Understanding how kidney injury develops after heart surgery
Official title: Methodology Study in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass to Investigate Mechanisms Involved in Cardiac Surgery-associated Acute Kidney Injury.
Run by Bayer · NCT06772025 · Data updated 2026-11-12
This study is trying to understand how kidney injury happens after heart surgery in patients who use a heart-lung machine, to help improve care for this common problem.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Bayer Industry-sponsored |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 4 sites (Bad Oeynhausen, North Rhine-Westphalia and 3 other locations) |
| Status | Recruiting |
| Started | February 3, 2025 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT06772025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older scheduled for specific cardiovascular surgeries involving cardiopulmonary bypass and with chronic kidney disease.
✕Probably not a fit
Patients undergoing emergency surgeries or those with severe anemia or systemic infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the mechanisms behind post-operative acute kidney injury (PO-AKI) in patients undergoing heart surgery with the use of a heart-lung machine. Researchers will analyze biomarkers in participants who develop PO-AKI within a week after surgery, focusing on the early hours and days post-operation. The study will include patients scheduled for specific cardiovascular surgeries involving cardiopulmonary bypass, and will not involve any investigational treatments. By understanding the development of PO-AKI, the study seeks to improve treatment and prevention strategies for this common complication.
Why it matters
Potential benefit: If successful, this study could lead to better prevention and treatment strategies for post-operative acute kidney injury in heart surgery patients.
How similar studies have gone: While the study focuses on understanding mechanisms of PO-AKI, similar studies have shown promise in identifying risk factors and biomarkers related to kidney injury in surgical settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant must be at least 18 years of age at the time of signing the informed consent form (ICF). * Participants who are scheduled for hospital admission for any of the following cardiovascular surgery interventions, alone or in combination, involving cardiopulmonary bypass (CPB): * Aortic, mitral, or tricuspid valve surgery (repair or replacement) * Aortic surgery * ≥3 coronary artery bypass grafts * Participant with: chronic kidney disease (CKD): 30 ≤ estimated glomerular filtration rate (eGFR) \< 90 mL/min/1.73 m\^2 Exclusion Criteria: * Emergency surgery situation * Anemia - hemoglobin \<10 g/dL * Clinical signs of systemic infection or other infection requiring anti-infective treatment (viral, bacterial, fungal, parasitic; single-dose prophylaxis allowed) * Systemic immunosuppressive or anti-inflammatory treatment including corticosteroids \>10 mg prednisolone equivalent/day * Any anti-cancer treatment within 3 months (e.g. immunotherapy, chemotherapy, radiotherapy) * Major surgery within 2 months * AKI within the last month * Prior renal transplants or RRT * Planned use of contrast media within 5 days prior to surgery or during surgery * Patient included in an interventional clinical trial involving a pharmacological intervention * Any reason that would make participation unadvisable, at the discretion of the investigator. * Autoimmune disorders such as anti-glomerular basement membrane (anti-GBM) diseases, systemic lupus erythematosus, chronic rheumatic heart diseases, acute rheumatic heart pericarditis, endocarditis, myocarditis, rheumatic mitral valve diseases, rheumatic aortic valve diseases
Where it's running
-
Herz- und Diabeteszentrum Nordrhein-Westfalen
Bad Oeynhausen, North Rhine-Westphalia, Germany Recruiting -
Royal Papworth Hospital | Cardiac Surgery
Cambridge, Cambridgeshire, United Kingdom Recruiting -
Harefield Hospital | Cardiology
Harefield, Greater London, United Kingdom Recruiting -
St Thomas' Hospital | Critical Care
London, Greater London, United Kingdom Recruiting
Study contacts
- Study coordinator: Bayer Clinical Trials Contact
- Email: clinical-trials-contact@bayer.com
- Phone: 18888422937
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BX-001N to prevent kidney injury after cardiac surgery with total circulatory arrest
This study will see if BX-001N can prevent acute kidney injury and later major kidney problems in adults undergoing cardiac surgery with total circulatory arrest.
-
Using ultrasound to prevent and treat kidney injury after heart surgery
This study is testing if using ultrasound to check for fluid buildup in the liver and kidneys can help prevent and treat kidney problems after heart surgery.
-
Kidney-surface versus limb NIRS monitoring to predict acute kidney injury after cardiac surgery with bypass
This study will try NIRS sensors placed over the kidneys versus on the limbs to see which better predicts acute kidney injury in adults having cardiac surgery with cardiopulmonary bypass.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.